Asian Oncology Research Journal

An Intriguing Case of Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma: A Case Report

Nidhin Rehman

Department of Pathology, Armed Forces Medical Services, India.

Magesh Kumar N

Department of Surgery, Armed Forces Medical Services, India.

Vasu Nikunj *

Department of Surgery, Armed Forces Medical Services, India.

Manikandan A

Department of ENT, Armed Forces Medical Services, India.

Deepti Mutreja

Department of Pathology, Armed Forces Medical Services, India.

*Author to whom correspondence should be addressed.

---

Abstract

Aims: Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, representing approximately 80% of all thyroid malignancies. Diffuse sclerosing variant (DSV) accounts for only 2% of all PTC. We present a case of this rare variant in an old lady and subsequently delve into the current understanding of DSV of PTC, drawing insights from various scholarly articles to illuminate its clinical significance, diagnostic challenges, and therapeutic implications.

Presentation of Case:  A 55-year-old lady presented with swelling in the right side of her neck. On examination, the swelling measured 2.5 x 2.5 cm, firm and moving with deglutition. Ultrasonography confirmed that the bulky right lobe of the thyroid replaced with cysts and nodules, leading to right hemithyroidectomy. Histomorphology confirmed DSV of PTC, following which underwent completion thyroidectomy with node dissection and adjuvant chemotherapy.

Discussion: DSV of PTC usually presents in middle-aged to older adults, with a slight female predominance. Being a rare variant, the diagnosis remains a major challenge. It is generally associated with a favourable prognosis, with low lymph node metastasis rates and distant spread. Surgical resection remains the main cornerstone of treatment, with adjuvant therapy reserved for high-risk cases.

Conclusion: DSV of PTC represents a rare and distinct variant of thyroid cancer with unique features. A multimodal approach is required for accurate diagnosis and treatment. More research in this field is required to explain the molecular mechanisms driving DSV and also novel therapeutic targets for this rare variant.

Keywords: Carcinoma, thyroid cancer, papillary, thyroid disease, thyroid gland, thyroid neoplasms, thyroid nodule

---

---

---

References

Yeh MW, Wu JX. Diffuse sclerosing papillary thyroid cancer: Excellent survival despite frequent nodal metastases. Ann Surg Oncol. 2023;30(8):4568.

Houas J, Ghammam M, Chouchane L, Abdessaied N, Omri M El, Bellakhdher M, et al. An unusual presentation of diffuse sclerosing variant of papillary thyroid carcinoma. Egypt J Otolaryngol. 2022;38(1):10–3.

Pillai S, Gopalan V, Smith RA, Lam AK. Diffuse sclerosing variant of papillary thyroid carcinoma—an update of its clinicopathological features and molecular biology. Critical reviews in oncology/hematology. 2015 Apr 1;94(1):64-73.

Cavaco D, Martins AF, Cabrera R, Vilar H, Leite V. Diffuse sclerosing variant of papillary thyroid carcinoma: outcomes of 33 cases. Eur Thyroid J. 2022;11(1).

Takagi N, Hirokawa M, Nobuoka Y, Higuchi M, Kuma S, Miyauchi A. Diffuse sclerosing variant of papillary thyroid carcinoma: A study of fine needle aspiration cytology in 20 patients. Cytopathology. 2014;25(3):199–204.

Ji YL, Jung HS, Han BK, Eun YK, Seok SK, Ji YK, et al. Diffuse sclerosing variant of papillary carcinoma of the thyroid: Imaging and cytologic findings. Thyroid. 2007;17(6):567–73.

Chow SM, Chan JK, Law SC, Tang DL, Ho CM, Cheung WY, Wong IS, Lau WH. Diffuse sclerosing variant of papillary thyroid carcinoma—clinical features and outcome. European Journal of Surgical Oncology (EJSO). 2003 Jun 1;29(5):446-9.

Elemam , Ibrahim Bakhit Y, Eman Abd elgadir M. Elshariff, Mohammed Abdelgader Elsheikh, Tibyan Abd Almajed Altaher, Ghanem Mohammed Mahjaf, Waha Ismail Yahia Abdelmula, and Babbiker Mohammed Taher Gorish. “Immunohistochemical Expression of P63 in Ovarian Tumors Among Sudanese Women”. International Research Journal of Oncology. 2024;7(1):14-20.

Available:https://journalirjo.com/index.php/IRJO/article/view/145.

Pillai S, Gopalan V, Smith RA, Lam AKY. Diffuse sclerosing variant of papillary thyroid carcinoma-an update of its clinicopathological features and molecular biology. Crit Rev Oncol Hematol. 2015;94(1):64–73.

Thompson LDR, Wieneke JA, Heffess CS. Diffuse sclerosing variant of papillary thyroid carcinoma: A clinicopathologic and immunophenotypic analysis of 22 cases. Endocr Pathol. 2005;16(4): 331–48.

Scholfield DW, Fitzgerald CW et al. Diffuse Sclerosing Papillary Thyroid Carcinoma: Clinicopathological Characteristics and Prognostic Implications Compared with Classic and Tall Cell Papillary Thyroid Cancer. Ann Surg Oncol. 2023 Aug;30(8):4761-4770.

Simon A Holoubek, Huan Yan et al. Aggressive variants of papillary thyroid microcarcinoma are associated with high-risk features, but not decreased survival. Surgery. 2020 Jan;167(1): 19-27.

Chereau N, Giudicelli X, Pattou F, Lifante JC, Triponez F, Mirallié E, et al. Diffuse sclerosing variant of papillary thyroid carcinoma is associated with aggressive histopathological features and a poor outcome: Results of a large multicentric study. J Clin Endocrinol Metab. 2016; 101(12):4603–10.